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Abstract
Infection with Chlamydia trachomatis targets epithelial cells within the genital tract which respond by secreting
chemokines and cytokines. Persistent inflammation can lead to fibrosis, tubal infertility and/or ectopic pregnancy;
many infections are asymptomatic. Most studies have investigated the inflammatory response in the initial stages of
infection, less is known about the later stages of infection, especially with a low, potentially asymptomatic, bacterial
load. Our objective was to determine the inflammatory mediators involved in clearance of low-grade infection and
the potential involvement in chronic inflammation. Six to eight week old C3H/HeJ mice were pretreated with 2.5 mg
medroxyprogesterone acetate on day -10 and -3 before infection. Mice (n=3 for 28 d, n=3 for 35 d) were infected
with 5 × 102 inclusion-forming units of C. trachomatis, serovar D; vaginal cultures were obtained weekly to monitor
infection. Control mice (n=3 for 28 d, n=3 for 35 d) were sham infected. Mice were killed on day 28 (experiment 1)
and day 35 (experiment 2) post-infection and vaginal tissue, uterine horns and oviducts collected for analysis of
mRNAs encoding inflammatory cytokines and chemokines. Total RNA was isolated and a superarray analysis
performed using mouse Cytokines and Chemokines PCR arrays (Qiagen, Valencia, CA). Statistical differences in
gene expression were determined using a paired Students t-test. At 28 days after infection, the expression of mRNA
encoding 6, 35 and 3 inflammatory genes differed from controls in vaginal, uterine and oviductal tissues, respectively
(P<0.05). At 35 days after infection, the expression of mRNA encoding 16, 38 and 14 inflammatory genes differed
from controls in vaginal, uterine and oviductal tissues, respectively (P<0.05). Understanding the mechanisms
involved in the inflammatory response at later stages of infection should aid in the development of treatment options
that minimize the development of asymptomatic, chronic inflammation-induced infertility.

Keywords: Chlamydia trachomatis; Oviduct;
Cytokines; Chemokines; Immune response

Inflammation;

Introduction
Chlamydia trachomatis is an obligate intracellular pathogen and the
most frequently reported sexually transmitted bacteria in the United
States [1]. C. trachomatis targets epithelial cells within the genital tract
initiating an immune response. Infectious load is correlated to clinical
pathogenesis [2,3]; infection with C. trachomatis is often
asymptomatic. If left untreated the bacteria can ascend to and infect
the oviducts [4,5]. Untreated C. trachomatis infection can lead to
persistent or recurrent inflammation, fibrosis, scarring, pelvic
inflammatory disease (PID), tubal infertility, and/or an increased
susceptibility to ectopic pregnancy [6,7].
Upon infection, C. trachomatis elementary bodies (EBs) invade host
epithelial cells in the genital tract. Within the host cells, EBs
differentiate into reticulate bodies (RBs) which actively replicate within
the host cell cytoplasm and then reorganize back into infectious EBs.
This biphasic life cycle as well as adaptation to evade the immune
response allows C. trachomatis to persist for extended periods within
host epithelial cells, inducing a chronic inflammatory response [8-12].
Previous studies have investigated the inflammatory response of C.
trachomatis in the initial stages of infection, including regulation by
cytokines, chemokines and inflammatory mediators involved in the
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recruitment of immune cells [5,8,10,13,14]. For example, Rasmussen et
al. [10] demonstrated that once C. trachomatis has established
infection within epithelial cells, the innate immune response allows for
the production of pro-inflammatory cytokines such as interleukins 1,
6, 8 (Il-1, Il-6, Il-8), tumor necrosis factor-alpha (TNF-α), and colony
stimulating factor 2 (CSF 2). Secretion of these cytokines and
chemokines recruit immune cells such as natural killer (NK) cells and
phagocytes. Following an established intracellular infection, the T-cell
mediated immune response then becomes the critical element required
for clearance [15]. However, evidence suggests that this T-cell response
also contributes to the pathology following infection. Th1 cells limit
replication of C. trachomatis, but Th2 cells inhibit Th1 responses
leading to continued production of pro-inflammatory cytokines which
can lead to fibrosis [16]. C. trachomatis also induces production of
TNF-α, which promotes apoptosis of infected and bystander cells [17].
Overall, understanding cytokine and chemokine regulation during
both acute and chronic phases of infection may contribute to the
development of treatment options that will minimize the long-term
inflammatory consequences attributed to this disease.
Limited investigation of the overall inflammatory response during
the later stages of infection has been performed, especially after
infection with a low bacterial load. For example, Maxion and Kelly [5]
used 107 IFUs of the mouse pneumonitis biovar of C. trachomatis and
reported that cytokine and chemokine expression differs in
anatomically distinct regions of the genital tract. Specifically, these
authors investigated the expression of chemokines associated with Th1
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and Th2 responses in the oviducts and cervical-vaginal regions of the
reproductive tract during the induction phase (0-14 days) and
resolution phase (14-35 days) of infection. Our objective was to
determine within the reproductive tract the concurrent level of
expression of mRNA encoding inflammatory mediators during the
later phases of infection using a relatively low infectious load of C.
trachomatis biovar, serovar D, one of the most prevalent serovars
involved in urogenital infections of humans [18]. Two separate
experiments were performed, with tissues collected at 4 and 5 weeks
after infection (experiment 1 and 2, respectively). Our hypothesis was
that mRNA encoding pro-inflammatory cytokines and chemokines
will be differentially expressed in the female reproductive tract of mice
infected with C. trachomatis at both 28 and 35 days post-infection
compared to controls.

Materials and Methods
Ethics statement
All animal experiments were performed according to the guidelines
and protocol approved by the University of California Irvine
Institutional Animal Care and Use Committee (protocol # 2009-2868).

Animal model
Using a previously described model of confirmed genital infection
by C. trachomatis, serovar D, female C3H/HeJ mice, 6- to 8-week old,
(Jackson Laboratories, Sacramento, CA) were pretreated with 2.5 mg
medroxyprogesterone acetate (SICOR Pharmaceuticals) on Days -10
and -3 before infection [19,20]. In both experiments mice were
infected via vaginal challenge with 5 × 102 inclusion-forming units
(IFUs) of C. trachomatis, serovar D in 0.01 mL of Eagle Minimal
essential media (MEM, Gibco) on Day 0, as previously described
[19,20]. Control mice were also pretreated with medroxyprogesterone
acetate, but were sham infected with Eagle Minimal essential media
(MEM, Gibco) alone. Vaginal swabs were obtained twice weekly after
infection and cell cultures were performed to monitor infection as
previously described [19-21].

2. Immediately before being sacrificed vaginal cultures were obtained
and all mice inoculated vaginally with C. trachomatis remained culture
positive but at a significantly lower level than that obtained throughout
the first two weeks of infection. Results of vaginal cultures following
infection with this strain/dose of C. trachomatis, serovar D have been
reported, including number of IFUs recovered [20]. Vaginal tissue,
uterine horns and the oviducts were collected and snap-frozen for later
extraction of RNA.

Isolation of RNA and gene expression analysis
Total RNA was extracted from each tissue sample using TRIzol
reagent (Invitrogen, Carlsbad, CA) and purified through RNeasy
columns (Qiagen, Valencia, CA). To determine the effect of treatment
on the expression of genes involved in the inflammatory response, a
targeted real time PCR SuperArray analysis was performed using RT2
Profiler PCR arrays for mouse Cytokines and Chemokines (Qiagen), as
previously described [22]. Real-time PCR were performed on an
Eppendorf Mastercycler ep realplex2 system (Eppendorf, Hamburg,
Germany).
Gene expression was standardized against GAPDH as a
housekeeping gene and analyzed by the 2−ΔΔCT method [23].
Statistical differences in the expression of mRNA were determined
using a paired Students t-test.

Results
Experiment 1: Expression of mRNA encoding inflammatory
genes in vaginal, uterine and oviduct tissues at 28 days postinfection
Gene expression analysis was used to determine the effect of
infection on the expression of inflammatory mRNAs at 28 days postinfection. In vaginal tissue collected at 28 days after infection, the
expression of mRNA encoding 6 inflammatory genes increased and no
genes decreased when compared to controls (Table 1).

Mice were killed on day 28 (n=3 for control and infected) in
experiment 1 and day 35 (n=3 for control and infected) in experiment
28 Day infected vs. control
Control Avg. ∆C+

Infected Avg.

SEM

∆C+ SEM

Ccl24

12.79 ± 0.76

Ccl3

Gene Symbol

Fold change

p‐value

10.62 ± 0.53

4.5

0.007

10.18 ± 0.54

7.81 ± 1.00

5.5

0.025

Ccl4

9.03 ± 0.59

6.28 ± 0.44

6.7

0.036

Cd40lg

14.01 ± 0.30

11.05 ± 0.36

7.8

0.011

Cxcl1

9.00 ± 0.25

6.18 ± 0.24

7.1

0.028

Il22

15.96 ± 0.37

15.03 ± 0.39

1.9

0.024

6.43 ± 0.17

6.51 ± 0.25

0.5

0.032

35 day infected vs. control
Bmp7
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Csf3

4.88 ± 0.05

5.47 ± 0.06

0.5

<0.001

Ccl4

9.03 ± 0.58

6.28 ± 0.23

4.2

0.019

Ctf1

6.67 ± 0.15

7.19 ± 0.12

0.6

0.023

Hprt

1.65 ± 0.14

1.81 ± 0.04

0.6

0.022

Ifna2

11.3 ± 0.19

11.41 ± 0.24

0.4

0.014

Ifng

13.04 ± 0.54

9.68 ± 0.43

8.5

0.035

Il10

9.94 ± 0.38

8.35 ± 0.32

2.8

0.048

Il11

11.76 ± 0.07

10.52 ± 0.23

2.3

0.03

Il18

5.86 ± 0.22

6.54 ± 0.06

0.4

0.014

Il1a

7.13 ± 0.09

5.97 ± 0.04

1.4

0.007

Il1rn

6.36 ± 0.37

5.95 ± 0.13

1.9

0.042

Mif

0.43 ± 0.12

0.76 ± 0.08

0.7

0.045

Pf4

5.15 ± 0.19

5.26 ± 0.06

0.6

0.031

Thpo

12.95 ± 0.6

13.76 ± 0.16

3.7

0.019

Tnf

8.4 ± 0.19

6.86 ± 0.09

2.4

0.002

Table 1: Effect of treatment on the expression of mRNAs in the vagina at 28 and 35 days post‐infection. The normalized average ∆C+ value was
calculated using GAPDH as the house‐keeping gene. Fold change values (infected over control) in gene expression are presented as average fold
change (2‐(average Ct)) for differentially expressed mRNAs (P<0.05).
In uterine samples collected at 28 days after infection, the
expression of mRNA encoding 32 inflammatory genes increased and 3
genes decreased when compared to controls (Table 2).
28 Day infected vs. control
Gene
Symbol

Control Avg. ∆C Infected Avg. ∆C+ Fold
+ SEM
SEM
Change

p-value

Ccl1

13.84 ± 0.32

12.03 ± 0.32

3.5

0.04

Ccl17

9.56 ± 0.11

7.76 ± 0.21

3.5

Ccl2

7.31 ± 0.29

4.53 ± 0.35

Ccl22

9.18 ± 0.13

Ccl24

Infected Avg. ∆C+ Fold
Change
SEM

p‐value

SEM
Il16

7.41 ± 0.17

6.24 ± 0.27

2.2

0.045

0.009

Il27

11.83 ± 0.11

9.70 ± 0.15

4.4

0.002

6.8

0.025

Lta

11.01 ± 0.21

9.01 ± 0.37

4

0.037

7.45 ± 0.31

3.3

0.025

Ltb

6.85 ± 0.16

3.58 ± 0.29

9.6

0.009

11.64 ± 0.13

12.81 ± 0.30

0.4

0.018

Tgfb2

0.67 ± 0.04

2.57 ± 0.76

0.3

0.03

Ccl3

11.52 ± 0.34

8.49 ± 0.13

8.2

0.001

Tnf

9.77 ± 0.22

6.93 ± 0.30

7.2

0.013

Ccl4

9.73 ± 0.39

6.41 ± 0.15

10

0.001

Tnfsf11

10.44 ± 0.47

8.68 ± 0.28

3.4

0.029

Ccl5

5.80 ± 0.05

1.75 ± 0.27

16.6

0.008

Xcl1

7.00 ± 0.19

5.29 ± 0.23

3.3

0.016

Cd40lg

14.40 ± 0.61

8.19 ± 0.35

74

0.016

Ccl12

7.01 ± 0.25

3.70 ± 0.30

9.9

0.015

Csf2

12.12 ± 0.45

9.31 ± 0.17

7

0.002

Ccl7

6.68 ± 0.33

3.63 ± 0.36

8.3

0.027

Cxcl10

8.91 ± 0.06

4.99 ± 0.31

15.1

0.012

Cxcl5

10.50 ± 0.10

5.42 ± 0.46

34

0.049

Cxcl13

7.80 ± 0.73

4.10 ± 0.13

13

0.001

Gusb

2.88 ± 0.09

2.27 ± 0.15

1.5

0.035

Cxcl16

5.19 ± 0.15

3.27 ± 0.20

3.8

0.008

Il12a

12.98 ± 0.35

11.79 ± 0.26

2.3

0.045
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Cxcl9

8.26 ± 0.21

2.47 ± 0.18

55.3

0.001

Il18

6.87 ± 0.06

5.92 ± 0.11

1.9

0.003

Fasl

10.13 ± 0.21

6.46 ± 0.20

12.8

0.002

Il1b

8.29 ± 0.52

5.55 ± 0.33

6.7

0.023

Ifna2

11.25 ± 0.08

12.23 ± 0.38

0.5

0.041

Osm

10.42 ± 0.13

8.05 ± 0.13

5.2

0.001

Ifng

11.30 ± 0.08

7.21 ± 0.28

17.1

0.006

Tnfsf10

5.96 ± 0.13

4.12 ± 0.29

3.6

0.02

Il12b

10.68 ± 0.24

8.07 ± 0.26

6.1

0.007

Table 2: Effect of treatment on the expression of mRNAs in the uterus at 28 days post‐infection. The normalized average ∆C+ value was calculated
using GAPDH as the house‐keeping gene. Fold change values (infected over control) in gene expression are presented as average fold change (2(average Ct)) for differentially expressed mRNAs (P<0.05).
Of the 6 inflammatory mRNAs that increased within vaginal tissue
after infection, 4 were also differentially affected by treatment in
uterine samples. In oviducts collected at 28 days post-infection, the
expression of mRNA encoding 2 inflammatory genes increased and 1
gene decreased. Of the 3 inflammatory genes affected by treatment
within the oviduct, mRNA encoding 1 gene, chemokine (c-c motif)
ligand 12 (Ccl12), was also increased in uterine samples.

Experiment 2: Expression of mRNA encoding inflammatory
genes in vaginal, uterine and oviduct tissues at 35 days postinfection
In vaginal tissue collected 35 days after infection, the expression of
mRNA encoding 8 inflammatory genes was increased and 8 decreased
when compared to controls (Table 1). In uterine samples collected at
35 days after infection, the expression of mRNA encoding 32
inflammatory genes increased and 6 genes decreased compared to
controls (Table 3).

35 day infected vs. control
Gene Symbol

Control Avg. Infected Avg.
Fold change
∆C+ SEM
∆C+ SEM

p‐Value

Gene symbol

control Avg. Infected Avg.
Fold change
∆C+ SEM
∆C+ SEM

p‐value

Ccl1

13.26 ± 0.25

11.66 ± 0.25

3

0.016

Il27

12.87 ± 0.30

9.73 ± 0.27

8.8

0.012

Ccl17

9.41 ± 0.15

7.97 ± 0.34

2.7

0.041

Lta

10.67 ± 0.19

9.22 ± 0.05

2.7

<0.001

Ccl2

6.72 ± 0.14

5.44 ± 0.17

2.4

0.007

Ltb

6.92 ± 0.19

4.28 ± 0.09

6.2

<0.001

Ccl22

8.69 ± 0.15

7.22 ± 0.15

2.8

0.005

Tgfb2

1.26 ± 0.14

3.70 ± 1.24

0.2

0.021

Ccl24

11.25 ± 0.08

13.93 ± 0.94

0.2

0.012

Tnf

9.73 ± 0.09

6.98 ± 0.28

6.7

0.013

Ccl3

10.83 ± 0.31

8.35 ± 0.08

5.6

<0.001

Tnfsf11

9.94 ± 0.12

9.06 ± 0.14

1.8

0.013

Ccl4

9.08 ± 0.23

6.26 ± 0.04

7

<0.001

Xcl1

7.12 ± 0.19

5.41 ± 0.40

3.3

0.05

Ccl5

5.47 ± 0.21

2.32 ± 0.09

8.9

<0.001

Adipoq

11.58 ± 1.29

6.81 ± 0.40

27.2

0.034

Cd40lg

13.94 ± 0.93

8.64 ± 0.16

39.4

0.001

Cd70

11.19 ± 0.19

10.38 ± 0.07

1.7

0.008

Csf2

11.51 ± 0.29

8.78 ± 0.16

6.6

0.002

Cntf

7.99 ± 0.08

8.62 ± 0.17

0.6

0.023

Cxcl10

9.18 ± 0.19

5.08 ± 0.27

17.1

0.005

Csf3

7.55 ± 0.15

6.56 ± 0.18

2

0.017

Cxcl13

8.83 ± 0.27

4.51 ± 0.36

20

0.017

Cxcl1

11.41 ± 0.43

7.49 ± 0.46

15.1

0.029

Cxcl16

5.00 ± 0.23

3.14 ± 0.13

3.6

0.002

Cxcl11

12.94 ± 0.27

6.26 ± 0.34

102.5

0.018

Cxcl9

8.06 ± 0.22

2.41 ± 0.26

50.3

0.006

Il10

11.18 ± 0.41

8.77 ± 0.15

5.3

0.003

Fasl

10.25 ± 0.04

6.92 ± 0.29

10.1

0.013

Il21

15.24 ± 0.15

10.55 ± 0.46

25.8

0.047

Ifna2

10.87 ± 0.31

12.36 ± 0.33

0.4

0.037

Il3

15.11 ± 0.11

14.13 ± 0.22

2

0.026

Ifng

10.76 ± 0.16

7.33 ± 0.09

10.8

<0.001

Thpo

11.89 ± 0.16

13.27 ± 0.36

0.4

0.02

Il12b

10.31 ± 0.23

8.46 ± 0.12

3.6

0.002

Tnfsf10

5.82 ± 0.18

3.80 ± 0.19

4

0.004
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Il16

7.75 ± 0.11

6.75 ± 0.20

2

0.02

Vegfa

4.23 ± 0.13

4.83 ± 0.09

0.7

0.023

Table 3: Effect of treatment on the expression of mRNAs in the uterus at 35 days post‐infection. The normalized average ∆C+ value was calculated
using GAPDH as the house‐keeping gene. Fold change values (infected over control) in gene expression are presented as average fold change (2‐
(average Ct)) for differentially expressed mRNAs (P<0.05).
Of the 16 inflammatory mRNAs affected by treatment in vaginal
tissue, 7 were also differentially expressed in uterine samples and 3 in
oviduct samples. In oviducts collected at 35 days post infection, the

expression of mRNA encoding 13 inflammatory genes was increased
and 1 gene decreased (Table 4).

28 Day infected vs. control
Gene Symbol

Control Avg. ∆C+ SEM

Infected Avg. ∆C+ SEM

Fold change

p‐value

Ccl12

6.81 ± 0.37

4.39 ± 0.51

5.3

0.045

Il13

10.45 ± 0.21

11.69 ± 0.28

0.4

0.029

Il23a

11.43 ± 0.10

10.96 ± 0.08

1.4

0.021

Bmp7

7.97 ± 0.21

6.99 ± 0.12

2

0.011

Ccl17

7.11 ± 0.52

6.19 ± 0.32

6.1

0.021

Cd40lg

13.02 ± 0.30

10.40 ± 0.36

6.2

0.03

Cx3cl1

5.16 ± 0.21

4.16 ± 0.18

2

0.025

Cxcl1

12.57 ± 0.25

9.99 ± 0.24

6

0.007

Fasl

12.75 ± 0.66

8.79 ± 0.34

15.6

0.019

Gpi1

2.71 ± 0.04

1.56 ± 0.26

2.2

0.039

Hsp90ab1

0.53 ± 0.18

1.98 ± 0.26

2.7

0.027

Il12b

13.10 ± 0.24

10.47 ± 0.17

6.2

0.003

Il1a

11.42 ± 0.22

9.65 ± 0.23

3.4

0.011

Il9

7.16 ± 0.21

8.21 ± 0.26

0.5

0.044

Lif

10.03 ± 0.38

8.77 ± 0.08

2.4

0.016

Mif

1.55 ± 0.09

0.17 ± 0.29

2.6

0.044

Osm

11.50 ± 0.44

9.93 ± 0.33

3

0.047

35 Day infected vs. control

Table 4: Effect of treatment on the expression of mRNAs in the oviduct at 28 and 35 days post‐infection. The normalized average ∆C+ value was
calculated using GAPDH as the house‐keeping gene. Fold change values (infected over control) in gene expression are presented as average fold
change (2‐(average Ct)) for differentially expressed mRNAs (P<0.05).
Of the 14 inflammatory mRNAs affected by treatment within the
oviduct, 5 were also differentially expressed in uterine samples and 3 in
vaginal tissue.

Discussion
The host response to infection with C. trachomatis includes the
induction of pro inflammatory cytokines and chemokines which leads
to innate and adaptive immune cell recruitment and activation [24].
Although the immune response is critical to the clearance of infection,
the cellular immune response in particular can cause tissue damage
that promotes fibrosis and can lead to infertility [16]. Considering that
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infection with C. trachomatis is often asymptomatic, the objective of
these two experiments was to identify inflammatory mediators
induced during the later phases of low-dose C. trachomatis genital
infection in order to advance our understanding of disease progression
and the immune response involved in potentially asymptomatic
chronic inflammation.
It is well known that susceptibility to C. trachomatis infection is
genetically controlled in mice. Both Tuffrey et al. [25-27] and Peterson
et al. [19-21] have shown that human serovars of C. trachomatis can
infect the genital tract of mice, specifically C3H/HeJ mice.
Progesterone pretreatment is necessary, but this strain of mice remains
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culture positive for more than 4 weeks following infection [20]. In the
current study, infected mice continued to have positive vaginal C.
trachomatis cultures for the duration of the experiments with IFUs
lower when the mice were killed compared to the first two weeks of
infection.
In experiment 1, mice were killed 28 days post-infection. In vaginal
tissue, mRNA encoding several cytokines and chemokines was affected
by infection with C. trachomatis. Among differentially-regulated genes
in vaginal samples, the expression of mRNA encoding chemokine (c-c
motif) ligand 4 (Ccl4), also known as macrophage inflammatory
protein-1β (MIP-1β), a potent lymphocyte chemo attractant, was
induced at 28 days of infection, with greater than a 6-fold increase
compared to controls. C-C motif chemokines are a subgroup of
chemokines with two adjacent cysteine residues near the amino
terminus [28]. Yilma et al. [29] reported an increase in Ccl4 production
in mouse macrophages during the early response to C. trachomatis
infection; therefore, our results suggest that this cytokine is actively
involved in both the early response and late phases of infection.
Interestingly, Ccl4 is highly related to macrophage inflammatory
protein-1α (Ccl3) and it is thought that these C-C motif chemokines
are secreted to recruit specific T cell subsets during the immune
response [30,31]. In our study, expression of mRNA encoding Ccl3 in
the vagina was also increased at 28 days post-infection.
Of all the differentially affected mRNAs in vaginal tissue, the largest
fold-change in 28 day infected samples was seen in the induction of
mRNA encoding CD40 ligand (Cd40lg). Cd40lg is mostly found on the
surface of CD4+ T cells and its interaction with Cd40 is required in the
activation of humoral and cellular immune responses [32].
Within the uterus, treatment affected the expression of mRNA for
five C-X-C motif chemokines. C-X-C motif chemokines are a
subgroup of chemokines that have amino terminus cysteine residues
separated by one amino acid [28]. Most notable is the induction of
mRNA encoding chemokine (c-x-c motif) ligand 9 (Cxcl9). Previous
studies have reported that Cxcl9 peaks during the early phases of
infection in the upper genital tract and may be involved in Th1
responses [5], our results suggest that within the uterus, Cxcl9mediated inflammation remains ongoing even after the initial phase of
infection. The expression of mRNA encoding several interleukins was
also induced in the infected mouse uterus at 28 days post-infection,
including Il1b, Il12a, Il12b, Il16, Il18, and Il27. Notably, Il12 is also
reported to be involved in Th1 responses [33]. In our results, mRNA
for Il12 subunit alpha (Il12a) and subunit beta (Il12b) was induced at
28 days after infection. Several tumor necrosis factor family members
and interferons were also induced, supporting the hypothesis that
inflammation remains active and ongoing within the uterus during the
late, resolution phase of infection.
When compared to the response observed in vaginal and uterine
tissues at 28 days, the oviduct had fewer mRNA differentially expressed
after infection of mice with C. trachomatis.
The expression of mRNA encoding two genes was increased and
one gene decreased. C. trachomatis-induced cell death within the
oviduct is of concern due to long term sequelae, especially when
considering that upon initial intracellular invasion of epithelial cells, C.
trachomatis has the ability to prevent apoptosis of infected cells,
therefore promoting infection [8,13,14]. Interestingly, the expression of
mRNA encoding fas ligand (TNF superfamily, member 6; Fasl), a key
mediator of apoptosis, was not affected by treatment at 28 days post
infection within the oviduct.
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In experiment 2, mice were killed 35 days post-infection. The level
of mRNA encoding 4 interleukins (Il10, Il11, Il1rn, Il1a) was increased
and 1 interleukin (Il18) decreased in vaginal tissue collected at 35 days
post-infection. Of these, Il18 is reported to interact with Il12 to
stimulate interferon gamma (IFN-γ) production from NK cells during
the early host response to infection [34]. Although studies have
reported that IFN-γ is crucial for immune cell responses to C.
trachomatis [34-36], the expression of mRNA for Il12 did not differ at
35 days after infection and there was a decrease in levels of mRNA for
Il18. Furthermore, IFN-γ had the greatest fold change of all
differentially induced mRNA in the infected vaginal tissues, suggesting
that IFN-γ production is being stimulated by other immunoregulatory
factors at this later stage of infection.
The increase in expression of mRNA encoding Il10 within vaginal
samples collected at 35 days after infection was not expected.
Interleukin-10 is considered an anti-inflammatory cytokine and a
recent study using C. trachomatis infected HeLa cells demonstrated
that exogenous Il10 treatment decreased several inflammatory
cytokines including TNF [37,38].
Similar to vaginal tissues, uterine samples collected 35 days postinfection with C. trachomatis had increased expression of Il10 and
TNF. Furthermore, an increase in adiponectin (Adipoq) was observed.
Similar to Il10, Adipoq has anti-inflammatory properties including
regulating cell defense and survival during stress conditions [39,40]. In
addition, a dramatic increase in the expression of mRNA for Cxcl11
(102-fold change) was observed. Cxcl11 shares features with Cxcl9 and
Cxcl10, including induction by interferons and expression on activated
Th1 cells [41,42]. It is reported that the Th1 response is crucial for
controlling C. trachomatis infection, our results that mRNA for these
transcripts were induced within the infected uterus is therefore
consistent with other studies.
Within the oviduct mRNA encoding 13 genes was increased and one
gene decreased at 35 days after infection. The expression of mRNA
encoding fasl increased at 35 days after infection with a 15-foldchange. In addition, changes in mRNA for other inflammatory
mediators involved in tissue damage were detected, including Il1-a,
which is released from lysed cells and acts by stimulating further
cytokine release from neighboring cells [10]. Interestingly, levels of
mRNA for Leukemia inhibitory factor (Lif) were increased in 35 day
infected oviducts. Guney et al. [43] demonstrated that LIF expression
is increased in the oviducts of woman with ectopic pregnancies
compared to non-pregnant woman. Furthermore, Ji et al. [44]
proposed that LIF facilitates implantation of the embryo in the oviduct
when the stromal surface is exposed due to epithelial cell shedding
caused by chronic inflammation. The results shown here warrant
further investigation especially since C. trachomatis have the ability to
not only disrupt infected epithelial cells, but also non-infected cells in
proximity to the infection [8]. In oviductal epithelia, these changes in
gene expression and disruption of cellular processes can increase the
risk of chronic inflammation-induced pelvic inflammatory disease and
infertility.
Overall, this study examined the coordinated and concurrent
expression of mRNA encoding multiple cytokines in spatially distinct
sections of the reproductive tract. We investigated the later stages of
infection using a relatively low infectious dose in order to obtain a
better understanding of the genetic mechanisms involved in chronic
inflammation and cellular damage. Differences in the magnitude of
response to infection in differing regions of the reproductive tract were
expected, as were differences in the level of expression of specific
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mRNAs within a tissue over time [5], illustrating well the dynamic
nature of the inflammatory response to infection and the need for
inclusive analyses of inflammatory mediators.
Understanding the mechanisms involved in the inflammatory
response at late stages of infection should aid in the development of
treatment options that minimize chronic inflammation-induced pelvic
inflammatory disease and infertility.

Acknowledgments
This work was supported by National Institutes of Health Grants
K12 DA014040 (P.J.B.), P01 HD071875 (P.J.B.), R33 AI079775 (E.M.P.),
the University of Kentucky, and Kentucky Agricultural Experiment
Station. The information reported in this paper (publication no.
15-07-104) is part of a project of the Kentucky Agricultural
Experiment Station and is published with approval of the Director.
The content is solely the responsibility of the authors and does not
necessarily represent the official views of the National Institute of
Allergy and Infectious Diseases or the National Institutes of Health.
The funders had no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.

References
1.
2.
3.
4.
5.
6.
7.
8.

9.
10.

11.
12.
13.
14.

CDC: Sexually transmitted disease surveillance (2009). Atlanta, GA: US
Department of Health and Human Services, CDC(2010).
Gomes JP, Borrego MJ, Atik B, Santo I, Azevedo J, et al. (2006)
Correlating Chlamydia trachomatis infectious load with urogenital
ecological success and disease pathogenesis. Microbes Infect 8: 16-26.
Agrawal T, Vats V, Salhan S, Mittal A (2009) Determination of chlamydial
load and immune parameters in asymptomatic, symptomatic and infertile
women. FEMS Immunol Med Microbiol 55: 250-257.
Paavonen J, Lehtinen M (1996) Chlamydial pelvic inflammatory disease.
Hum Reprod Update 2: 519-529.
Maxion HK, Kelly KA (2002) Chemokine expression patterns differ
within anatomically distinct regions of the genital tract during Chlamydia
trachomatis infection. Infect Immun 70: 1538-1546.
Soper DE (2010) Pelvic inflammatory disease. Obstetrics and gynecology
116: 419-428.
Miyairi I, Ramsey KH, Patton DL (2010) Duration of untreated
chlamydial genital infection and factors associated with clearance: review
of animal studies. Infectious Diseases 201, Suppl 2: 96-103.
Kessler M, Zielecki J, Thieck O, Mollenkopf HJ, Fotopoulou C (2012)
Chlamydia trachomatis disturbs epithelial tissue homeostasis in fallopian
tubes via paracrine Wnt signaling. American journal of pathology 180:
186-198.
Moulder JW (1991) Interaction of chlamydiae and host cells in vitro.
Microbiol Rev 55: 143-190.
Rasmussen SJ, Eckmann L, Quayle AJ, Shen L, Zhang YX (1997)
Secretion of proinflammatory cytokines by epithelial cells in response to
Chlamydia infection suggests a central role for epithelial cells in
chlamydial pathogenesis. Clinical Investigation 99: 77-87.
Zhong G, Fan P, Ji H, Dong F, Huang Y (2001) Identification of a
chlamydial protease like activity factor responsible for the degradation of
host transcription factors. J Exp Med 193: 935-942.
Zhong G, Fan T, Liu L (1999) Chlamydia inhibits interferon gammainducible major histocompatibility complex class II expression by
degradation of upstream stimulatory factor 1.J Exp Med189: 1931-1938.
Igietseme JU, Omosun Y, Partin J, Goldstein J, He Q(2013) Prevention of
Chlamydia-induced infertility by inhibition of local caspase activity. J
Infect Dis 207: 1095-1104.
Zhong G (2011) Chlamydia trachomatis secretion of proteases for
manipulating host signaling pathways. Front Microbiol 2: 14.

Reprod Syst Sex Disord
ISSN:2161-038X RSSD, an open access journal

15.
16.
17.

18.
19.

20.

21.
22.
23.
24.
25.
26.

27.
28.
29.
30.
31.

32.
33.
34.

Belay T, Eko FO, Ananaba GA, Bowers S, Moore T(2002) Chemokine and
chemokine receptor dynamics during genital chlamydial infection. Infect
Immun 70: 844-850.
Brunham RC, Rey-Ladino J (2005) Immunology of Chlamydia infection:
implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 5:
149-161.
Darville T, O'Neill JM, Andrews CW, Jr., Nagarajan UM, Stahl L(2003)
Toll like receptor-2, but not Toll-like receptor-4, is essential for
development of oviduct pathology in chlamydial genital tract infection. J
Immunol 171: 6187-6197.
Byrne GI (2010) Chlamydia trachomatis strains and virulence: rethinking
links to infection prevalence and disease severity. J Infect Dis 201 Suppl 2:
126-133.
Peterson EM, You JZ, Motin V, de la Maza LM (1999) Intranasal
immunization with Chlamydia trachomatis, serovar E, protects from a
subsequent vaginal challenge with the homologous serovar. Vaccine 17:
2901-2907.
Slepenkin A, Chu H, Elofsson M, Keyser P, Peterson EM (2011)
Protection of mice from a Chlamydia trachomatis vaginal infection using
a Salicylidene acylhydrazide, a potential microbicide. Infectious Diseases
204: 1313-1320.
Peterson EM, Cheng X, Motin VL, de la Maza LM (1997) Effect of
immunoglobulin G isotype on the infectivity of Chlamydia trachomatis
in a mouse model of intravaginal infection. Infect Immun 65: 2693-2699.
Bridges PJ, Jeoung M, Shim S, Park JY, Lee JE(2012) Hematopoetic
prostaglandin D synthase: an ESR1-dependent oviductal epithelial cell
synthase. Endocrinology 153: 1925-1935.
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data
using real time quantitative PCR and the 2(-Delta Delta C(T)) Method.
Methods 25: 402-408.
Darville T, Hiltke TJ (2010) Pathogenesis of genital tract disease due to
Chlamydia trachomatis.Infectious Diseases 201 Suppl 2: 114-125.
Tuffrey M, Alexander F, Woods C, Taylor-Robinson D (1992) Genetic
susceptibility to chlamydial salpingitis and subsequent infertility in mice.
J Reprod Fertil 95: 31-38.
Tuffrey M, Alexander F, Conlan W, Woods C, Ward M (1992)
Heterotypic protection of mice against chlamydial salpingitis and
colonization of the lower genital tract with a human serovar F isolate of
Chlamydia trachomatis by prior immunization with recombinant serovar
L1 major outer-membrane protein. J Gen Microbiol 138 Pt 8: 1707-1715.
Tuffrey M, Alexander F, Taylor-Robinson D (1990) Severity of salpingitis
in mice after primary and repeated inoculation with a human strain of
Chlamydia trachomatis. J Exp Pathol (Oxford) 71: 403-410.
Laing KJ, Secombes CJ (2004) Chemokines. Dev Comp Immunol 28:
443-460.
Yilma AN, Singh SR, Morici L, Dennis VA (2013) Flavonoid Naringenin:
A Potential Immunomodulator for Chlamydia trachomatis Inflammation.
Mediators Inflamm 2013: 102457.
Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ (1993)
Preferential migration of activated CD4+ and CD8+ T cells in response to
MIP-1 alpha and MIP-1 beta. Science260: 355-358.
Schall TJ, Bacon K, Camp RD, Kaspari JW, Goeddel DV (1993) Human
macrophage inflammatory protein alpha (MIP-1 alpha) and MIP-1 beta
chemokines attract distinct populations of lymphocytes. J Exp Med 177:
1821-1826.
Teruel M, Simeon CP, Broen J, Vonk MC, Carreira P, et al. (2012) Analysis
of the association between CD40 and CD40 ligand polymorphisms and
systemic sclerosis. Arthritis Res Ther 14: 154.
Perry LL, Feilzer K, Caldwell HD (1997) Immunity to Chlamydia
trachomatis is mediated by T helper 1 cells through IFN-gammadependent and -independent pathways. J Immunol 158: 3344-3352.
Hook CE, Matyszak MK, Gaston JS (2005) Infection of epithelial and
dendritic cells by Chlamydia trachomatis results in IL-18 and IL-12
production, leading to interferon gamma production by human natural
killer cells. FEMS immunology and medical microbiology 45: 113-120.

Volume 4 • Issue 3 • 1000152

Citation:

Cerny KL, Fleet MV, Slepenkin A, Peterson EM, Bridges PJ (2015) Differential Expression of mRNA Encoding Cytokines and
Chemokines in the Reproductive Tract after Infection of Mice with Chlamydia trachomatis . Reprod Syst Sex Disord 4: 1000152. doi:

10.4172/2161-038X.1000152

Page 8 of 8
35.
36.

37.

38.
39.

Ito JI, Lyons JM (1999) Role of gamma interferon in controlling murine
chlamydial genital tract infection. Infect Immun 67: 5518-5521.
Al-Zeer MA, Al-Younes HM, Lauster D, Abu Lubad M, Meyer TF (2013)
Autophagy restricts Chlamydia trachomatis growth in human
macrophages via IFNG-inducible guanylate binding proteins. Autophagy
9: 50-62.
Yilma AN, Singh SR, Fairley SJ, Taha MA, Dennis VA (2012) The antiinflammatory cytokine, interleukin-10, inhibits inflammatory mediators
in human epithelial cells and mouse macrophages exposed to live and
UV-inactivated Chlamydia trachomatis. Mediators of inflammation 2012:
520174.
Sabat R, Grutz G, Warszawska K, Kirsch S, Witte E(2010) Biology of
interleukin-10.Cytokine Growth Factor Rev 21: 331-344.
Wu L, Xu B, Fan W, Zhu X, Wang G(2013) Adiponectin protects Leydig
cells against proinflammatory cytokines by suppressing the nuclear
factor-kappaB signaling pathway. The FEBS journal 280: 3920-3927.

Reprod Syst Sex Disord
ISSN:2161-038X RSSD, an open access journal

40.
41.
42.
43.
44.

Kobayashi H, Ouchi N, Kihara S, Walsh K, Kumada M (2004) Selective
suppression of endothelial cell apoptosis by the high molecular weight
form of adiponectin. Circ Res 94: 27-31.
Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L (1996) Chemokine
receptor specific for IP10 and mig: structure, function, and expression in
activated T-lymphocytes. Experimental Medicine 184: 963-969.
Yang CH, Wei L, Pfeffer SR, Du Z, Murti A (2007) Identification of
CXCL11 as a STAT3-dependent gene induced by IFN. Immunology 178:
986-992.
Guney M, Erdemoglu E, Oral B, Karahan N, Mungan T (2008) Leukemia
inhibitory factor (LIF) is immunohistochemically localized in tubal
ectopic pregnancy. Acta Histochemica 110: 319-323.
Ji YF, Chen LY, Xu KH, Yao JF, Shi YF (2009) Locally elevated leukemia
inhibitory factor in the inflamed fallopian tube resembles that found in
tubal pregnancy. Fertility and Sterility 91: 2308-2314.

Volume 4 • Issue 3 • 1000152

